References
Reinherz, E.L.; Schlossman, S.F.: Regulation of the immune response: inducer and suppressor T-lymphocyte subsets in human beings. New Engl. J. med.505: 370–373 (1980).
Reinherz, E.L.; Kung, P.C.; Goldstein, G.; Levey, R.H.; Schlossman, S.F.: Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc. natn. Acad. Sci. USA77: 1588–1592 (1980).
Reinherz, E.L.; Morimoto, C.; Fitzgerald, K.A.; Hussey, R.E.; Daly, J.F.; Schlossman, S.F.: Heterogeneity of human T4+ inducer T-cells defined by a monoclonal antibody that delineates two functional subpopulations. J. Immun.128: 463–468 (1982).
Thomas, Y.; Rogozinski, L.; Irigoyen, O.H.; Shen, H.H.; Talle, M.A.; Goldstein, G.; Chess, L.: Functional analysis of human T-cell subsets defined by monoclonal antibodies. V. Suppressor cells within the activated OKT4+ population belong to a distinct subset. J. Immun.128: 1386–1390 (1982).
Van Wauwe, J.P.; DeMey, J.R.; Gossens, J.G.: OKT3: a monoclonal anti-human T-lymphocyte with potent mitogenic properties. J. Immun.124: 2708–2713 (1980).
Meuer, S.C.; Hodgdon, J.C.; Cooper, D.A.; Hussay, R.E.; Fitzgerald, K.A.; Schlossman, S.F.; Reinherz, E.L.: Human cytotoxic T-cell clones directed at autologous virus transformed targets: further evidence for lineage of genetic restriction to T4 and T8 surface glycoproteins. J. Immun.131: 186–190 (1983).
Weite, K.; Platzer, E.; Wang, C.Y.; Kan, E.A.R.; Moore, M.A.S.; Mertelsmann, R.: OKT8 antibody inhibits OKT3-induced IL2 production and proliferation in OKT8+ cells. J. Immun.131: 2356–2361 (1983).
Moroz, C.; Stevens, R.H.: Suppression of immunoglobulin production in normal human B-lymphocytes by two T-cell subsets distinguished following in vitro treatment with adenosine. Clin. Immunol. Immunopathol.75: 44–51 (1980).
Birch, R.E.; Polmar, S.H.: Pharmacological modification of immunoregulatory T-lymphocytes. I. Effect of adenosine, H1, and H2 histamine agonists upon T-lymphocyte regulation of B-lymphocyte differentiation in vitro. Clin. exp. Immunol.48: 218–230 (1982).
Birch, R.E.; Rosenthal, A.K.; Polmar, S.H.: Pharmacological modulation of immunoregulatory T-lymphocytes. II. Modulation of T-lymphocyte cell surface characteristics. Clin. exp. Immunol.48: 231–238 (1982).
Londos, C.; Wolff, J.: Two distinct adenosine sensitive sites on adenylate cyclase. Proc. natn. Acad. Sci. USA74: 5482–5486 (1977).
Polmar, S.H.; Birch, R.E.; Mandler, R.; Rudolph, S.A.: Adenosine and cyclic nucleotides in the modulation of immune responses; in Berne, Rall, Rubio, Regulatory function of adenosine, pp. 249–259 (Nijhoff, The Hague 1983).
Birch, R.E.; Polmar, S.H.: Adenosine induced immunosuppression: the relationship of adenosine induced biochemical events to the alteration of lymphocyte surface phenotype and the development of suppressor activity (submitted for publication, 1984).
Rocklin, R.E.: Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. J. clin. Invest.57: 1051–1058 (1976).
Garovoy, M.R.; Reddish, M.A.; Rocklin, R.E.: Histamine-induced suppressor factor (HSF): inhibition of helper T-cell generation and function. J. Immun.130: 357–361 (1983).
Rocklin, R.E.; Greineder, D.; Littman, B.H.; Melmon, K.L.: Modulation of cellular immune function in vitro by histamine receptor-bearing lymphocytes: mechanism of action. Cell. Immunol.37: 162–173 (1978).
Rocklin, R.E.; Blidy, A.; Kamal, M.: Physiochemical characterization of human histamine-induced suppressor factor. Cell Immunol.76: 243–252 (1983).
Beer, DJ.; Rosenwasser, L.J.; Dinarello, C.A.; Rocklin, R.E.: Cellular interactions in the generation and expression of histamine induced suppressor activity. Cell Immunol.69: 101–112 (1982).
Goodwin, J.S.; Webb, D.R.: Regulation of the immune response by prostaglandins. Clin. Immunol. Immunopathol.15: 106–122 (1980).
Rola-Pleszczynski, M.; Borgeat, P.; Sirois, P.: Leukotriene B4 induces human suppressor lymphocytes. Biochem. biophys. Res. Commun.108: 1531–1537 (1982).
Rola-Pleszczynski, M.; Sirois, P.: Leukotrienes as immunoregulators; in Piper, Leukotrienes and other lipoxygenase products, pp. 234–240 (Wiley & Sons, London 1983).
Berne, R.M.; Knabb, R.M.; Ely, S.W.; Rubio, R.: Adenosine in the local regulation of blood flow: a brief overview. Fed. Proc.42: 3136–3142 (1983).
Kammer, G.M.; Birch, R.E.; Polmar, S.H.: Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T-lymphocyte generation. J. Immun.130: 1706–1712 (1983).
Mandler, R.; Birch, R.E.; Polmar, S.H.; Kammer, G.M.; Rudolph, S.A.: Abnormal adenosine-induced immunosuppression and cAMP metabolism in T-lymphocytes of patients with systemic lupus erythematosus. Proc. natn. Acad. Sci. USA79: 7542–7546 (1982).
Author information
Authors and Affiliations
Additional information
Supported by research grants (AI 17570, AI 20086 and CA 38353) from the US Public Health Service, National Institutes of Health, DHHS.
Rights and permissions
About this article
Cite this article
Polmar, S.H. Pharmacological modification of immunoregulatory activity of lymphocytes: Facts and potential1. Surv. immunol. Res. 3, 274–279 (1984). https://doi.org/10.1007/BF02919043
Issue Date:
DOI: https://doi.org/10.1007/BF02919043